About the Authors
- Coby M. M. Laarakkers
-
Affiliations Laboratory of Genetic, Endocrine and Metabolic Diseases, Department of Laboratory Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands, Hepcidinanalysis.com, Nijmegen, The Netherlands
- Erwin T. Wiegerinck
-
Affiliations Laboratory of Genetic, Endocrine and Metabolic Diseases, Department of Laboratory Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands, Hepcidinanalysis.com, Nijmegen, The Netherlands
- Siem Klaver
-
Affiliations Laboratory of Genetic, Endocrine and Metabolic Diseases, Department of Laboratory Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands, Hepcidinanalysis.com, Nijmegen, The Netherlands
- Maria Kolodziejczyk
-
Affiliation Pieris AG, Freising, Germany
- Hendrik Gille
-
Affiliation Pieris AG, Freising, Germany
- Andreas M. Hohlbaum
-
Affiliation Pieris AG, Freising, Germany
- Harold Tjalsma
-
Contributed equally to this work with: Harold Tjalsma, Dorine W. Swinkels
Affiliations Laboratory of Genetic, Endocrine and Metabolic Diseases, Department of Laboratory Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands, Hepcidinanalysis.com, Nijmegen, The Netherlands
- Dorine W. Swinkels
-
Contributed equally to this work with: Harold Tjalsma, Dorine W. Swinkels
* E-mail: d.swinkels@labgk.umcn.nl
Affiliations Laboratory of Genetic, Endocrine and Metabolic Diseases, Department of Laboratory Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands, Hepcidinanalysis.com, Nijmegen, The Netherlands
Competing Interests
CMML, ETW, SK, HT and DWS are employees of the Radboud University Medical Centre (Nijmegen, The Netherlands) that amongst others offers hepcidin measurements to the medical scientific and pharmaceutical communities through a service unit called “hepcidinanalysis.com” on a fee per sample basis. MK, HG and AMH are employees of Pieris AG (Freising, Germany), an independent, clinical stage biotechnology company advancing its proprietary Anticalin technology to create safer, more efficacious and more convenient protein therapeutics. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data.
Author Contributions
Conceived and designed the experiments: CMML HT DWS. Performed the experiments: CMML ETW SK MK. Analyzed the data: CMML ETW SK HT DWS. Contributed reagents/materials/analysis tools: HG AMH HT DWS. Wrote the paper: CMML HG AMH HT DWS.